Document:

<PAGE>
                                                                     EXHIBIT 4.1

NO. 1

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT
AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY STATE
SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE
OF SUCH REGISTRATION OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY TO THE
EFFECT THAT SUCH REGISTRATION IS NOT REQUIRED.

                       WARRANT TO PURCHASE 933,800 SHARES
                               OF COMMON STOCK OF
                              deCODE genetics, INC.
                           (VOID AFTER MARCH 1, 2007)

         This certifies that ISLANDSBANKI HF., KIRKJUSANDI, REYKJAVIK, ICELAND
or its assigns (the "Holder"), for value received, is entitled to purchase from
deCODE genetics, Inc., a Delaware corporation (the "Company"), a maximum of
933,800 fully paid and nonassessable shares of the Company's Common Stock
("Common Stock") for cash at a price of $15.00 per share (the "Stock Purchase
Price") at any time or from time to time up to and including 5:00 p.m.
(Greenwich Mean Time) on March 1, 2007 the "Expiration Date"), upon surrender to
the Company at its principal office (or at such other location as the Company
may advise the Holder in writing) of this Warrant properly endorsed with the
Form of Subscription attached hereto duly filled in and signed and, if
applicable, upon payment in cash or by check of the aggregate Stock Purchase
Price for the number of shares for which this Warrant is being exercised
determined in accordance with the provisions hereof.

         This Warrant is subject to the following terms and conditions:

         1.       EXERCISE; ISSUANCE OF CERTIFICATES; PAYMENT FOR SHARES.

                  1.1 GENERAL. This Warrant is exercisable at the option of the
Holder of record hereof, at any time or from time to time, up to the Expiration
Date for all or any part of the shares of Common Stock (but not for a fraction
of a share) which may be purchased hereunder. The Company agrees that the shares
of Common Stock purchased under this Warrant shall be and are deemed to be
issued to the Holder hereof as the record owner of such shares as of the close
of business on the date on which this Warrant shall have been surrendered,
properly endorsed, the completed, executed Form of Subscription delivered and
payment made for such shares. Certificates for the shares of Common Stock so
purchased, together with any other securities or property to which the Holder
hereof is entitled upon such exercise shall be delivered to the Holder hereof by
the Company at the Company's expense within a reasonable time after the rights
represented by this Warrant have been so exercised. In case of a purchase of
less than all the shares which may be purchased under this Warrant, the Company
shall cancel this Warrant and execute and deliver a new Warrant or Warrants of
like tenor for the balance of the shares purchasable under the Warrant
surrendered upon such purchase to the Holder hereof within a reasonable time.
Each stock certificate so delivered shall be in such denominations of Common
Stock as may be requested by the Holder hereof and shall be registered in the
name of such Holder.

                  1.2 CONVERSION RIGHTS. Notwithstanding any provisions herein
to the contrary, if the Fair Market Value (as hereinafter defined) of the
Company's Common Stock is greater than the Stock Purchase Price (at the date of
calculation as set forth below), in lieu of exercising this Warrant for cash,
the Holder may

                                       1
<PAGE>
elect to convert this Warrant (or a portion thereof) to shares equal to the
value (as determined below) of this Warrant (or the portion thereof being
canceled) by surrender of this Warrant at the principal office of the Company
together with the properly endorsed Form of Subscription and notice of such
election in which event the Company shall issue to the Holder a number of shares
of Common Stock computed using the following formula:

                           X = Y (A-B)
                               -------
                                 A

         Where             X =      the number of shares of Common Stock to be
                                    issued to the Holder

                           Y =      the number of shares of Common Stock
                                    purchasable under the Warrant or, if only a
                                    portion of the Warrant is being exercised,
                                    the portion of the Warrant being canceled
                                    (at the date of such calculation)

                           A =      the average Fair Market Value (as defined
                                    below) of the Company's Common Stock for the
                                    5 trading days immediately preceding the
                                    date of such calculation)

                           B =      Stock Purchase Price (as adjusted to the
                                    date of such calculation)

As used in this Warrant, "Fair Market Value" on any date shall mean the average
closing price per share of Company's Common Stock on such date. The closing
price for each such day shall be the last sale price or, in case no such sale
takes place on such day, the average of the closing bid and asked prices, in
either case on the principal securities exchange on which the shares of such
Common Stock of the Company are listed or admitted to trading or, if applicable,
the last sale price, or in case no sale takes place on such day, the average of
the closing bid and asked prices of such Common Stock on the Nasdaq Stock Market
or any comparable system, or if such Common Stock is not reported on the Nasdaq
Stock Market or a comparable system, the average of the closing bid and asked
prices as furnished by two members of the National Association of Securities
Dealers, Inc. selected from time to time by the Company for that purpose. If
such bid and asked prices are not available, then Fair Market Value shall mean
the fair market value of the Common Stock as determined by the Company's Board
of Directors in good faith.

                  1.3 AUTOMATIC CONVERSION. If the Fair Market Value of the
Company's Common Stock is greater than $24.00 for a period of 30 consecutive
trading days prior to the Expiration Date, then on the first trading day
following the end of such 30-day period, this Warrant shall be converted
automatically without any further action by the Holder as follows:

                           (a) if the Holder delivers the Warrant and the
aggregate Stock Purchase Price to the Company at its principal office on such
day, the Company shall issue and deliver to the Holder a certificate for the
number of shares of Common Stock into which this Warrant was convertible on the
date on which such automatic conversion occurred; or

                           (b) if the Holder does not deliver the Warrant and/or
the aggregate Purchase Price to the Company on such day, the Company shall issue
and deliver to the Holder a certificate for the number of shares of Common Stock
into which this Warrant was convertible on the date on which such automatic
conversion occurred using the cashless conversion process set forth in Section
1.2 above; provided, however, that the Company shall not be obligated to issue
certificates evidencing the shares of Common Stock issuable upon such conversion
unless this Warrant is delivered to the Company at its principal office.

                                       2
<PAGE>
      2. REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY. The Company
hereby represents, warrants and covenants to the Holder as follows.

                  2.1 DUE ORGANIZATION. The Company is a corporation duly
organized, validly existing and in good standing under the laws of the State of
Delaware and is in good standing as a foreign corporation in each jurisdiction
in which the nature of its business makes such qualification necessary. The
Company has all requisite corporate power and authority to carry out its
business as presently conducted and as proposed to be conducted and to enter
into and discharge its obligations under this Warrant.

                  2.2 DUE EXECUTION. The execution and delivery of this Warrant
by the Company and its performance and compliance with the terms of this Warrant
have been duly authorized by all necessary corporate action on the part of the
Company.

                  2.3 NO CONFLICTS OR DEFAULTS. The consummation of the
transactions contemplated by this Warrant will not (i) conflict with, result in
any breach of any of the terms and provisions of, or constitute (with or without
notice or lapse of time or both) a default under, the certificate of
incorporation or bylaws of the Company, or any contract, agreement, indenture,
loan agreement, receivables purchase agreement, mortgage, deed of trust, or
other agreement or instrument to which the Company is a party or by which it or
any of its properties is bound, (ii) result in the creation or imposition of any
lien, adverse claim or other encumbrance upon any of the properties of the
Company pursuant to the terms of any such contract, agreement, indenture, loan
agreement, receivables purchase agreement, mortgage, deed of trust, or other
agreement or instrument, or (iii) violate any law or order, rule or regulation
applicable to the Company of any court or of any federal or state regulatory
body, administrative agency, or other governmental instrumentality having
jurisdiction over the Company or any of its properties.

                  2.4 BINDING OBLIGATION OF THE COMPANY. The Warrant constitutes
a legal, valid and binding obligation of the Company and is enforceable against
the Company in accordance with the terms hereof, except as enforcement may be
limited by applicable bankruptcy, insolvency, reorganization, moratorium or
other similar laws affecting creditors' rights generally and by general
principles of equity (whether considered in a proceeding or action in equity or
at law).

                  2.5 SHARES TO BE FULLY PAID; RESERVATION OF SHARES. All shares
of Common Stock which may be issued upon the exercise of the rights represented
by this Warrant will, upon issuance, be duly authorized, validly issued, fully
paid and nonassessable and free from all preemptive rights of any shareholder
and free of all taxes, liens and charges with respect to the issue thereof.
During the period within which the rights represented by this Warrant may be
exercised, the Company will at all times have authorized and reserved, for the
purpose of issue or transfer upon exercise of the subscription rights evidenced
by this Warrant, a sufficient number of shares of authorized but unissued Common
Stock, or other securities and property, when and as required to provide for the
exercise of the rights represented by this Warrant. The Company will take all
such action as may be necessary to assure that such shares of Common Stock may
be issued as provided herein without violation of any applicable law or
regulation, or of any requirements of any domestic securities exchange upon
which the Common Stock may be listed; provided, however, that the Company shall
not be required to effect a registration under any securities laws with respect
to such exercise. The Company will not take any action which would result in any
adjustment of the Stock Purchase Price (as set forth in Section 3 hereof) if the
total number of shares of Common Stock issuable after such action upon exercise
of all outstanding warrants, together with all shares of Common Stock then
outstanding and all shares of Common Stock then issuable upon exercise of all
options and upon the conversion of all convertible securities then outstanding,
would exceed the total number of shares of Common Stock then authorized by the
Company's Amended and Restated Certificate of Incorporation.

                                       3
<PAGE>
         3. ADJUSTMENT OF STOCK PURCHASE PRICE AND NUMBER OF SHARES. The Stock
Purchase Price and the number of shares purchasable upon the exercise of this
Warrant shall be subject to adjustment from time to time upon the occurrence of
certain events described in this Section 3. Upon each adjustment of the Stock
Purchase Price, the Holder of this Warrant shall thereafter be entitled to
purchase, at the Stock Purchase Price resulting from such adjustment, the number
of shares obtained by multiplying the Stock Purchase Price in effect immediately
prior to such adjustment by the number of shares purchasable pursuant hereto
immediately prior to such adjustment, and dividing the product thereof by the
Stock Purchase Price resulting from such adjustment.

                  3.1 SUBDIVISION OR COMBINATION OF STOCK. In case the Company
shall at any time subdivide its outstanding shares of Common Stock into a
greater number of shares, the Stock Purchase Price in effect immediately prior
to such subdivision shall be proportionately reduced, and conversely, in case
the outstanding shares of Common Stock of the Company shall be combined into a
smaller number of shares, the Stock Purchase Price in effect immediately prior
to such combination shall be proportionately increased.

                  3.2 DIVIDENDS IN COMMON STOCK, OTHER STOCK, PROPERTY,
RECLASSIFICATION. If at any time or from time to time the Holders of Common
Stock (or any shares of stock or other securities at the time receivable upon
the exercise of this Warrant) shall have received or become entitled to receive,
without payment therefor,

                           (a) Common Stock or any shares of stock or other
securities which are at any time directly or indirectly convertible into or
exchangeable for Common Stock, or any rights or options to subscribe for,
purchase or otherwise acquire any of the foregoing by way of dividend or other
distribution,

                           (b) any cash paid or payable otherwise than as a cash
dividend, or

                           (c) Common Stock or additional stock or other
securities or property (including cash) by way of spinoff, split-up,
reclassification, combination of shares or similar corporate rearrangement,
(other than shares of Common Stock issued as a stock split or adjustments in
respect of which shall be covered by the terms of Section 3.1 above), then and
in each such case, the Holder hereof shall, upon the exercise of this Warrant,
be entitled to receive, in addition to the number of shares of Common Stock
receivable thereupon and without payment of any additional consideration
therefor, the amount of stock and other securities and property (including cash
in the cases referred to in clause (b) above and this clause (c)) which such
Holder would hold on the date of such exercise had he been the holder of record
of such Common Stock as of the date on which holders of Common Stock received or
became entitled to receive such shares or all other additional stock and other
securities and property.

                  3.3 REORGANIZATION, RECLASSIFICATION, CONSOLIDATION, MERGER OR
SALE. If any recapitalization, reclassification or reorganization of the capital
stock of the Company, or any consolidation or merger of the Company with another
corporation, or the sale of all or substantially all of its assets or other
transaction shall be effected in such a way that holders of Common Stock shall
be entitled to receive stock, securities, or other assets or property (an
"Organic Change"), then, as a condition of such Organic Change, lawful and
adequate provisions shall be made by the Company whereby the Holder hereof shall
thereafter have the right to purchase and receive (in lieu of the shares of the
Common Stock of the Company immediately theretofore purchasable and receivable
upon the exercise of the rights represented hereby) such shares of stock,
securities or other assets or property as may be issued or payable with respect
to or in exchange for a number of outstanding shares of such Common Stock equal
to the number of shares of such stock immediately theretofore purchasable and
receivable upon the exercise of the rights represented hereby; provided,
however, that in the event the value of the stock, securities or other assets or
property (determined in good faith by the Board of Directors of the Company)
issuable or payable with respect to one share of the Common Stock of the Company

                                       4
<PAGE>
immediately theretofore purchasable and receivable upon the exercise of the
rights represented hereby is in excess of the Stock Purchase Price hereof
effective at the time of a merger and securities received in such
reorganization, if any, are publicly traded, then this Warrant shall expire
unless exercised prior to such Organic Change. In the event of any Organic
Change, appropriate provision shall be made by the Company with respect to the
rights and interests of the Holder of this Warrant to the end that the
provisions hereof (including, without limitation, provisions for adjustments of
the Stock Purchase Price and of the number of shares purchasable and receivable
upon the exercise of this Warrant) shall thereafter be applicable, in relation
to any shares of stock, securities or assets thereafter deliverable upon the
exercise hereof. The Company will not effect any such consolidation, merger or
sale unless, prior to the consummation thereof, the successor corporation (if
other than the Company) resulting from such consolidation or the corporation
purchasing such assets shall assume the obligation to deliver to such Holder
such shares of stock, securities or assets as, in accordance with the foregoing
provisions, such Holder may be entitled to purchase.

                  3.4 CERTAIN EVENTS. If any change in the outstanding Common
Stock of the Company or any other event occurs as to which the other provisions
of this Section 3 are not strictly applicable or if strictly applicable would
not fairly protect the purchase rights of the Holder of the Warrant in
accordance with such provisions, then the Board of Directors of the Company
shall make an adjustment in the number and class of shares available under the
Warrant, the Stock Purchase Price or the application of such provisions, so as
to protect such purchase rights as aforesaid. The adjustment shall be such as
will give the Holder of the Warrant upon exercise for the same aggregate Stock
Purchase Price the total number, class and kind of shares as he would have owned
had the Warrant been exercised prior to the event and had he continued to hold
such shares until after the event requiring adjustment.

                  3.5 NOTICES OF CHANGE.

                           (a) Immediately upon any adjustment in the number or
class or shares subject to this Warrant and of the Stock Purchase Price, the
Company shall give written notice thereof to the Holder, setting forth in
reasonable detail and certifying the calculation of such adjustment.

                           (b) The Company shall give written notice to the
Holder at least 10 business days prior to the date on which the Company closes
its books or takes a record for determining rights to receive any dividends or
distributions.

                           (c) The Company shall also give written notice to the
Holder at least 30 business days prior to the date on which an Organic Change,
or any liquidation or dissolution of the Company, shall take place.

                           (d) The Company shall also give written notice to the
Holder at least 10 business days prior to issuing any rights, warrants or other
securities to holders of Common Stock as a class entitling them to purchase any
additional shares of Common Stock or any other rights, warrants or other
securities.

         4. ISSUE TAX. The issuance of certificates for shares of Common Stock
upon the exercise of the Warrant shall be made without charge to the Holder of
the Warrant for any issue tax (other than any applicable income taxes) in
respect thereof, provided, however, that the Company shall not be required to
pay any tax which may be payable in respect of any transfer involved in the
issuance and delivery of any certificate in a name other than that of the then
Holder of the Warrant being exercised.

         5. CLOSING OF BOOKS. The Company will at no time close its transfer
books against the transfer of any warrant or of any shares of Common Stock
issued or issuable upon the exercise of any warrant in any manner which
interferes with the timely exercise of this Warrant.

                                       5
<PAGE>
         6. NO VOTING OR DIVIDEND RIGHTS; LIMITATION OF LIABILITY. Nothing
contained in this Warrant shall be construed as conferring upon the Holder
hereof the right to vote or to consent or to receive notice as a shareholder of
the Company or any other matters or any rights whatsoever as a shareholder of
the Company. No dividends or interest shall be payable or accrued in respect of
this Warrant or the interest represented hereby or the shares purchasable
hereunder until, and only to the extent that, this Warrant shall have been
exercised. No provisions hereof, in the absence of affirmative action by the
Holder to purchase shares of Common Stock, and no mere enumeration herein of the
rights or privileges of the Holder hereof, shall give rise to any liability of
such Holder for the Stock Purchase Price or as a shareholder of the Company,
whether such liability is asserted by the Company or by its creditors.

         7. WARRANTS TRANSFERABLE. Subject to compliance with applicable
securities laws and the legend set forth at the top of this Warrant, this
Warrant and all rights hereunder are transferable, in whole or in part, without
charge to the Holder hereof (except for transfer taxes), upon surrender of this
Warrant properly endorsed. Each taker and Holder of this Warrant, by taking or
holding the same, consents and agrees that this Warrant, when endorsed in blank,
shall be deemed negotiable, and that the Holder hereof, when this Warrant shall
have been so endorsed, may be treated by the Company, at the Company's option,
and all other persons dealing with this Warrant as the absolute owner hereof for
any purpose and as the person entitled to exercise the rights represented by
this Warrant, or to the transfer hereof on the books of the Company any notice
to the contrary notwithstanding; but until such transfer on such books, the
Company may treat the registered owner hereof as the owner for all purposes.

         8. DEMAND REGISTRATION RIGHTS.

                   8.1        DEMAND REGISTRATION.

                   (a) As used herein, "Registrable Stock" shall mean the Common
Stock purchased or purchasable hereunder. If, at any time prior to the
termination of the registration rights hereunder pursuant to Section 8.10, and
subject to the conditions of this Section 8.1, the Company shall receive a
written request from the Holders of more than fifty percent (50%) of the
Registrable Stock (the "Initiating Holders") that the Company file a
registration statement under the Securities Act of 1933 (the "Securities Act")
covering the registration of Registrable Stock, then the Company shall, within
thirty (30) days of the receipt thereof, give written notice of such request to
all Holders of Registrable Stock, and subject to the limitations of this Section
8.1 will use its best efforts to effect, as soon as practicable, the
registration under the Securities Act of all Registrable Stock that the Holders
of such Registrable Stock, within fifteen (15) days after the giving of such
notice, request to be registered, and keep such registration effective for a
period of one hundred twenty (120) days or until the Holders have completed the
distribution described in such registration statement, whichever period is
shorter.

                   (b) If the Initiating Holders intend to distribute the
Registrable Stock covered by their request by means of an underwriting, they
shall so advise the Company as a part of their request made pursuant to this
Section 8.1 and the Company shall include such information in the written notice
referred to in Section 8.1(a). In such event, the right of any Holder to include
its Registrable Stock in such registration shall be conditioned upon such
Holder's participation in such underwriting and the inclusion of such Holder's
Registrable Stock in the underwriting (unless otherwise mutually agreed by a
majority in interest of the Initiating Holders and such Holder) to the extent
provided herein. All Holders proposing to distribute their securities through
such underwriting shall enter into an underwriting agreement in customary form
with the underwriter or underwriters selected for such underwriting by a
majority in interest of the Initiating Holders (which underwriter or
underwriters shall be reasonably acceptable to the Company). Notwithstanding any
other provision of this Section 8.1 but subject to Section 8.1(f), if the
underwriter advises the Company that

                                       6
<PAGE>
marketing factors require a limitation of the number of securities to be
underwritten (including Registrable Stock), then the Company shall so advise all
Holders of Registrable Stock which would otherwise be underwritten pursuant
hereto, and the number of shares that may be included in the underwriting shall,
subject to Section 8.1(f), be allocated to the Holders of such Registrable Stock
on a pro rata basis based on the number of shares Registrable Stock held by all
such Holders (including the Initiating Holders). Any Registrable Stock excluded
or withdrawn from such underwriting shall be withdrawn from the registration.

                  (c) The Company shall not be required to effect more than one
(1) registration pursuant to this Section 8.1.

                  (d) Notwithstanding the foregoing, the Company shall not be
required to effect any registration pursuant to paragraph (a) above (i) during
the twelve (12) consecutive months following the effective date of a
registration statement filed in connection of any previous registration pursuant
to Section 8.2 below, or (ii) at any time when another registration statement
(other than on Form S-8) of the Company (A) is reasonably foreseen by the Board
to be filed with the Securities and Commission (the "SEC") within thirty (30)
days after the request pursuant to paragraph (a) above, (B) has been filed and
not yet become effective, or (C) has become effective less than six (6) months
prior to the date of the request for registration pursuant to paragraph (a)
above.

                  (e) The Company may postpone for 180 days the filing of a
registration statement pursuant to paragraph (a) above if the Company has
delivered a certificate to the Holders of the Registrable Stock stating that the
Board, acting in good faith, has determined that pursuance of such registration
statement would be seriously detrimental to the Company and its shareholders;
provided, however, that in the event of any such postponement the Holder(s)
shall be entitled to withdraw the request for such registration and, if such
request is withdrawn, such request shall not count as exercise of the Holder's
one-time right pursuant to paragraph (a) above; provided further that the
Company shall not defer its obligation in this manner more than once in any
twelve-month period.

                  (f) The Holder hereof acknowledges that Other Holders (as
hereinafter defined) may have the right to include their stock of the Company in
such registration statement and that if the offering is underwritten and the
underwriter advises the Company in writing that in its good faith opinion the
number of shares of stock requested to be included in such registration exceeds
the number that can be sold in such offering without adversely affecting such
underwriter's ability to effect an orderly distribution of such stock, the
Company may include in such registration statement the Other Registrable Stock
(as hereinafter defined) before it includes the Registrable Stock; provided
however that, if any Registrable Stock requested to be included in such
registration statement pursuant to paragraph (a) above is not so included
pursuant to this Section 8.1(f), such request shall not count as exercise of the
Holder's rights pursuant to paragraph (a) above.

                  8.2.     PIGGYBACK REGISTRATION.

                  (a) If the Company proposes to register any of its Common
Stock with the express purpose of issuing said Common Stock for cash (other than
on Form S-8), the Company shall give notice to the Holder hereof in writing of
such intention, at least thirty (30) days prior to the filing of the
registration statement in connection with such registration. Upon the written
request of the Holder given within fifteen (15) days after giving of any such
notice, the Company shall include in such registration all of the Registrable
Stock indicated in such request(s) of such Holder, so as to permit the
disposition of the stock so requested. In addition, the Holder requesting
registration shall provide to the Company as soon as practicable, but in no
event more than five (5) days after furnishing the Company with the written
request referred to in the preceding sentence, any information that is necessary
for the Company to prepare and file with the SEC a registration statement with
respect to such Registrable Stock. Thereafter, the Company shall effect the
registration of the

                                       7
<PAGE>
Registrable Stock, in accordance with the terms hereof, and use its best efforts
to keep such registration statement effective until the distribution is
complete, if underwritten, or otherwise for ninety (90) days. If a Holder
decides not to include all of its Registrable Stock in any registration
statement thereafter filed by the Company, such Holder shall nevertheless
continue to have the right to include any Registrable Stock in any subsequent
registration statement or registration statements as may be filed by the Company
with respect to offerings of its securities, all upon the terms and conditions
set forth in this Section 8.2.

                  (b) Notwithstanding any other provision of this Section 8.2,
the Company may cancel its intention to file a registration statement or
withdraw at any time any registration statement filed pursuant hereto, in
accordance with all applicable provisions of the Securities Act or the
Securities Exchange Act of 1934 (the "Exchange Act"), for any reason, including
but not limited to the discovery of material adverse information relating to the
Company or its condition, business, prospects or general market conditions.

                  (c) Notwithstanding any other provision of this Section 8.2,
if the registration statement under which the Company gives notice is for an
underwritten offering and if the managing underwriter advises the Company in
writing that in its good faith opinion the number of shares of stock requested
to be included in such registration exceeds the number that can be sold in such
offering without adversely affecting such underwriter's ability to effect an
orderly distribution of such stock, the Company will include in such
registration:

                           (i)      first, the number of shares of stock
                                    proposed to be included by the Company
                                    pursuant to Section 8.2(a) that, in the good
                                    faith opinion of such underwriters, can be
                                    sold; and

                           (ii)     second, the amount of the Company's stock
                                    held by holders other than the Holders of
                                    Registrable Stock ("Other Holders"), which
                                    stock is subject to registration rights
                                    ("Other Registrable Stock") that, in the
                                    opinion of such underwriters, can be sold;
                                    and

                           (iii)    third, the amount of Registrable Stock held
                                    by the Holder that, in the good faith
                                    opinion of such underwriters, can be sold,
                                    provided that if, in the opinion of the
                                    managing underwriter, less than all such
                                    stock requested to be included can be
                                    included in such registration, then
                                    allocation among the Holders of Registrable
                                    Stock shall be made pro rata among such
                                    Holders participating in such registration
                                    on the basis of the number of shares of
                                    stock which each Holder seeking to
                                    participate in such registration has
                                    requested be included in such registration;
                                    provided, however, that in any event, all of
                                    the Company's stock and all of the Other
                                    Registrable Stock that has been requested to
                                    be included in such registration must be
                                    included in such registration prior to any
                                    other stock.

                  8.3. REGISTRATION PROCEDURES. Whenever required under this
Warrant to effect the registration of any Registrable Stock, the Company shall,
as expeditiously as possible:

                  (a) Prepare and file with the SEC a registration statement
with respect to such Registrable Stock and use its reasonable best efforts to
cause such registration statement to become effective, subject to the Company's
right to withdraw such registration statement as provided in Section 8.2(b).

                  (b) Prepare and file with the SEC such amendments and
supplements to such registration statement and the prospectus used in connection
with such registration statement as may be reasonably

                                       8
<PAGE>
necessary to comply with the provisions of the Securities Act with respect to
the disposition of all Registrable Stock covered by such registration statement.

                  (c) Furnish to the Holders whose Registrable Stock is included
in such registration statement such numbers of copies of a prospectus, including
a preliminary prospectus, in conformity with the requirements of the Securities
Act, and such other documents as they may reasonably request in order to
facilitate the disposition of Registrable Stock owned by them.

                  (d) Use all reasonable efforts to register and qualify the
securities covered by such registration statement under such other United States
federal or state securities or blue sky laws of such jurisdictions as shall be
reasonable requested by the Holders whose Registrable Stock is included in such
registration, provided that the Company shall not be required in connection
therewith or as a condition thereto to qualify to do business or to file a
general consent to service of process in any states or jurisdictions.

                  (e) In the event of any underwritten public offering, enter
into and perform its obligations under an underwriting agreement, in usual and
customary form, with the managing underwriter of such offering. Each Holder
participating in such underwriting shall also enter into and perform its
obligations under such an agreement.

                  (f) Notify each Holder covered by such registration statement
at any time when a prospectus relating thereto is required to be delivered under
the Securities Act of the happening of any event as a result of which the
prospectus included in such registration statement, as then in effect, includes
an untrue statement of a material fact or omits to state a material fact
required to be stated therein or necessary to make the statements therein not
misleading in the light of the circumstances then existing, in which event such
Holder shall forthwith discontinue disposition of its Registrable Stock pursuant
to such prospectus until it is advised in writing by the Company that the use of
such prospectus may be resumed or until such holder receives copies of any
supplement or amendment to such prospectus, provided, however, that such
suspensions shall not be in effect for more than 90 days in any 12 month period.

                  (g) Cause all Registrable Stock registered pursuant hereunder
to be listed on each securities exchange (or The Nasdaq National Market) on
which similar securities issued by the Company are then listed.

                  (h) Provide a transfer agent and register for all Registrable
Stock registered pursuant hereunder and a CUSIP for all such Registrable Stock,
in each case not later than the effective date of such registration.

                  (i) Take such action under the securities laws of such states
of the United States as any participating Holder shall reasonably request;
provided, however, that the Company shall not be required to qualify to do
business as a foreign corporation, or to file any general consent to service of
process, in any state.

                  8.4 REGISTRATION EXPENSES. All expenses incurred in connection
with any registration hereunder, including all printing and related expenses,
shall be borne by the Company; provided, however, that each of the Holders
participating in a registration shall pay its own legal fees and its pro rata
portion of the discounts or commissions payable to any underwriter.

                  8.5 INDEMNIFICATION. In the event of any registered offering
of Registrable Stock pursuant to this Agreement:

                  (a) The Company will indemnify and hold harmless, to the
fullest extent permitted by law, any Holder and any underwriter for such Holder,
and each person, if any, who controls the Holder or such

                                       9
<PAGE>
underwriter, from and against any and all losses, damages, claims, liabilities,
joint or several, costs and expenses (including any amounts paid in any
settlement effected with the Company's prior written consent) to which the
Holder or any such underwriter or controlling person may become subject under
applicable law or otherwise, insofar as such losses, damages, claims,
liabilities (or actions or proceedings in respect thereof), costs or expenses
arise out of or are based upon (i) any untrue statement or alleged untrue
statement of any material fact contained in the registration statement or
included in the prospectus, as amended or supplemented, or (ii) the omission or
alleged omission to state therein a material fact required to be stated therein
or necessary to make the statements therein, in the light of the circumstances
in which they are made, not misleading, and the Company will reimburse the
Holder, such underwriter and each such controlling person of the Holder or the
underwriter, promptly upon demand, for any reasonable legal or any other
expenses incurred by them in connection with investigating, preparing to defend
or defending against or appearing as a third-party witness in connection with
such loss, claim, damage, liability, action or proceeding; provided, however,
that the Company will not be liable in any such case to the extent that any such
loss, damage, liability, cost or expense arises out of or is based upon any
untrue statement or omission in such registration statement or prospectus so
made in conformity with information furnished to the Company in writing by a
Holder, such underwriter or such controlling persons specifically for use in
such registration statement; provided, further, that this indemnity shall not be
deemed to relieve any underwriter of any of its due diligence obligations;
provided, further, that the indemnity agreement contained in this Section 8.5(a)
shall not apply to amounts paid in settlement of any such claim, loss, damage,
liability or action if such settlement is effected without the consent of the
Company, which consent shall not be unreasonably withheld. Such indemnity shall
remain in full force and effect regardless of any investigation made by or on
behalf of the Holder, the underwriter or any controlling person of the Holder or
the underwriter, and regardless of any sale in connection with such offering by
the Holder. Such indemnity shall survive the transfer of securities by a Holder.

                  (b) Each Holder participating in a registration hereunder will
indemnify and hold harmless the Company (including but not limited to its
directors, officers, employees, agents and representatives), any underwriter for
the Company, and each person, if any, who controls the Company or such
underwriter, from and against any and all losses, damages, claims, liabilities,
costs or expenses (including any amounts paid in any settlement effected with
the Holder's consent) to which the Company (including but not limited to its
directors, officers, employees, agents and representatives) or any such
controlling person and/or any such underwriter may become subject under
applicable law or otherwise, insofar as such losses, damages, claims,
liabilities (or actions or proceedings in respect thereof), costs or expenses
arise out of or are based on an untrue statement or omission in such
registration statement or prospectus based on written information furnished to
the Company by such Holder specifically for use in such registration statement,
and each such Holder will reimburse the Company (including but not limited to
its directors, officers, employees, agents and representatives), any underwriter
and each such controlling person of the Company or any underwriter, promptly
upon demand, for any reasonable legal or other expenses incurred by them in
connection with investigating, preparing to defend or defending against or
appearing as a third-party witness in connection with such loss, claim, damage,
liability, action or proceeding; provided, however, that this indemnity shall
not be deemed to relieve any underwriter of any of its due diligence
obligations; provided, further, that the indemnity agreement contained in this
Section 8.5(b) shall not apply to amounts paid in settlement of any such claim,
loss, damage, liability or action if such settlement is effected without the
consent of the Holders, as the case may be, which consent shall not be
unreasonably withheld; and provided that in no event shall any indemnity under
this Section 8.5(b) exceed the gross proceeds from the offering received by the
Holder.

                  (c) Promptly after receipt by an indemnified party pursuant to
the provisions of Section 8.5(a) or 8.5(b) of notice of the commencement of any
action involving the subject matter of the foregoing indemnity provisions, but
in any event no fewer than ten (10) days before the date designated in such
notice as the date by which an answer must be served (or such extension thereof,
provided that the extension has been granted in writing by the plaintiff and
that no admission or consent to jurisdiction or other waiver has been

                                       10
<PAGE>
granted or implied by the request for such an extension), such indemnified party
will, if a claim thereof is to be made against the indemnifying party pursuant
to the provisions of said Section 8.5(a) or 8.5(b), promptly notify the
indemnifying party of the commencement thereof. In the event such action is
brought against any indemnified party and it notifies the indemnifying party of
the commencement thereof, the indemnifying party shall have the right to
participate in, and, to the extent that it may wish, jointly with any other
indemnifying party similarly notified, to assume the defense thereof with
counsel reasonably satisfactory to such indemnified party; provided, however,
that if the defendants in any action include both the indemnified party and the
indemnifying party and there is a conflict of interests which would prevent
counsel for the indemnifying party from also representing the indemnified party,
the indemnified party or parties shall have the right to select one separate
counsel to participate in the defense of such action on behalf of such
indemnified party or parties. After notice from the indemnifying party to such
indemnified party of its election so to assume the defense thereof, the
indemnifying party will not be liable to such indemnified party pursuant to the
provisions of said Section 8.5(a) or 8.5(b) for any legal or other expense
subsequently incurred by such indemnified party in connection with the defense
thereof, unless (i) the indemnified party shall have employed counsel in
accordance with the provision of the preceding sentence, (ii) the indemnifying
party shall not have employed counsel reasonably satisfactory to the indemnified
party to represent the indemnified party within a reasonable time after the
notice of the commencement of the action and within 15 days after written notice
of the indemnified party's intention to employ separate counsel pursuant to the
previous sentence, or (iii) the indemnifying party has authorized the employment
of counsel for the indemnified party at the expense of the indemnifying party.
No indemnifying party will consent to entry of any judgment or enter into any
settlement which does not include as an unconditional term thereof the giving by
the claimant or plaintiff to such indemnified party of a release from all
liability in respect to such claim or litigation.

                  8.6. CONTRIBUTION. If for any reason the foregoing indemnity
is unavailable, or is insufficient to hold harmless an indemnified party (except
as specifically provided therein), then the indemnifying party shall contribute
to the amount paid or payable by the indemnified party as a result of such
losses, claims, damages, liabilities or expenses (i) in such proportion as is
appropriate to reflect the relative benefits received by the indemnifying party
on the one hand and the indemnified party on the other from the registration or
(ii) if the allocation provided by clause (i) above is not permitted by
applicable law, or provides a lesser sum to the indemnified party than the
amount hereinafter calculated, in such proportion as is appropriate to reflect
not only the relative benefits received by the indemnifying party on the one
hand and the indemnified party on the other but also the relative fault of the
indemnifying party and the indemnified party as well as any other relevant
equitable considerations. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent
misrepresentation.

                  8.7 DESIGNATION OF UNDERWRITER. The Company shall have the
right to designate the underwriters in any underwritten offering pursuant to
Section 8.2 and to approve underwriters in any other underwritten offerings.

                  8.8 CONDITIONS TO REGISTRATION OBLIGATIONS. The Company shall
not be obligated to effect the registration of Registrable Stock pursuant to
this Agreement unless the Holder thereof consents to the following:

                  (a) conditions requiring the Holder to comply with all
applicable provisions of the Securities Act and the Exchange Act including, but
not limited to, the prospectus delivery requirements of the Securities Act, and
to furnish to the Company information about sales made in such public offering;

                  (b) conditions prohibiting the Holder upon receipt of
telegraphic or written notice from the Company that it is required by law to
correct or update the registration statement or prospectus from

                                       11
<PAGE>
effecting sales of the Registrable Stock until the Company has completed the
necessary correction or updating; and

                  (c) conditions prohibiting the sale of Registrable Stock by
such Holder during the process of the registration until the registration
statement is effective.

                  8.9. LOCK UP. In connection with any underwritten registration
of Registrable Stock pursuant to Section 8.2 above and to the extent the Holder
participates in any such offering, the Holder agrees to abide by the "lock-up"
period as is required by the underwriter in such registration (but in no event
shall such "lock-up" period be greater than 180 days) and further agree to
execute such further documents as may be required by the underwriters to
effectuate such "lock-up." In addition, no Holder may participate in any
underwritten registration hereunder unless such person (i) agrees to sell such
person's securities on the basis provided in customary underwriting arrangements
and (ii) provides all relevant information and completes and executes all
questionnaires, powers of attorney, indemnities, underwriting agreements and
other documents required under the terms of such underwriting arrangements.

                  8.10. TERMINATION. The registration rights granted under this
Warrant will terminate on the first date on which all of the Registrable Stock
held by the Holder hereof may be sold pursuant to Rule 144 in any three-month
period.

         9. RIGHTS AND OBLIGATIONS SURVIVE EXERCISE OF WARRANT. The rights and
obligations of the Company, of the holder of this Warrant and of the of shares
of Common Stock issued upon exercise of this Warrant shall survive the exercise
of this Warrant.

         10. MODIFICATION AND WAIVER. This Warrant and any provision hereof may
be changed, discharged or terminated only by an instrument in writing signed by
the party against which enforcement of the same is sought.

         11. NOTICES. Any notice, request or other document required or
permitted to be given or delivered to the Holder hereof or the Company shall be
deemed to have been given when delivered personally or sent by facsimile or
certified mail, postage prepaid, to each such Holder at its address as shown on
the books of the Company or to the Company at the address indicated therefore in
the first paragraph of this Warrant or such other address as either may from
time to time provide to the other.

         12. BINDING EFFECT ON SUCCESSORS. This Warrant shall be binding upon
any corporation succeeding the Company by merger, consolidation or acquisition
of all or substantially all of the Company's assets. All of the covenants and
agreements of the Company shall inure to the benefit of the successors and
assigns of the Holder hereof, and the word "Holder" as used herein shall be
deemed to include such successors and assigns, provided that any transfer of
this Warrant is made in accordance with the requirements hereof.

         13. DESCRIPTIVE HEADINGS AND GOVERNING LAW. The description headings of
the several sections and paragraphs of this Warrant are inserted for convenience
only and do not constitute a part of this Warrant. This Warrant shall be
construed and enforced in accordance with, and the rights of the parties shall
be governed by, the laws of the State of New York.

         14. LOST WARRANTS. The Company represents and warrants to the Holder
hereof that upon receipt of evidence reasonably satisfactory to the Company of
the loss, theft, destruction, or mutilation of this Warrant and, in the case of
any such loss, theft or destruction, upon receipt of an indemnity reasonably
satisfactory to the Company, or in the case of any such mutilation upon
surrender and cancellation of such

                                       12
<PAGE>
Warrant, the Company, at its expense, will make and deliver a new Warrant, of
like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant.

         15. FRACTIONAL SHARES. No fractional shares shall be issued upon
exercise of this Warrant. The Company shall, in lieu of issuing any fractional
share, pay the Holder entitled to such fraction a sum in cash equal to such
fraction multiplied by the then effective Stock Purchase Price.

                      [THIS SPACE INTENTIONALLY LEFT BLANK]

                                       13
<PAGE>
         IN WITNESS WHEREOF, the Company has caused this Warrant to be duly
executed by its officer, thereunto duly authorized this 6th day of May, 2002.

                                             deCODE genetics, INC.
                                             a Delaware corporation

                                             By:  /s/ Kari Stefansson
                                                  Kari Stefansson
                                                  President and CEO

                                       14
<PAGE>
                                    EXHIBIT A

                                SUBSCRIPTION FORM

                                                  Date:

deCODE genetics, Inc.

Attn:  President

Ladies and Gentlemen:

:        The undersigned hereby elects to exercise the warrant issued to it by
         deCODE genetics, Inc. (the "Company") and dated ______________, Warrant
         No. ______, (the "Warrant") and to purchase thereunder ___________
         shares of the Common Stock of the Company (the "Shares") at a purchase
         price of ______________ per Share or an aggregate purchase price of
         $________________ (the "Purchase Price").

:        The undersigned hereby elects to convert ____________________ percent
         (____%) of the value of the Warrant pursuant to the provisions of
         Section 1.2 of the Warrant.

         Pursuant to the terms of the Warrant the undersigned has delivered the
Purchase Price herewith in full in cash or by certified check or wire transfer.
The undersigned also makes the representations set forth on the attached Exhibit
B of the Warrant.

                                        Very truly yours,

                                        By:

                                        Title:
<PAGE>
                                    EXHIBIT B

                            INVESTMENT REPRESENTATION

THIS AGREEMENT MUST BE COMPLETED, SIGNED AND RETURNED TO deCODE genetics, INC.
ALONG WITH THE SUBSCRIPTION FORM BEFORE THE COMMON STOCK ISSUABLE UPON EXERCISE
OF THE WARRANT DATED _______________, WILL BE ISSUED.

                                                  Date:

deCODE genetics, Inc.

Attn:  President

Ladies and Gentlemen:

         The undersigned, __________________________ ("Purchaser"), intends to
acquire up to shares of the Common Stock (the "Common Stock") of deCODE
genetics, Inc. (the "Company") from the Company pursuant to the exercise or
conversion of certain Warrants to purchase Common Stock held by Purchaser. The
Common Stock will be issued to Purchaser in a transaction not involving a public
offering and pursuant to an exemption from registration under the Securities Act
of 1933, as amended (the "Securities Act") and applicable state securities laws.
In connection with such purchase and in order to comply with the exemptions from
registration relied upon by the Company, Purchaser represents, warrants and
agrees as follows:

         Purchaser is acquiring the Common Stock for its own account, to hold
for investment, and Purchaser shall not make any sale, transfer or other
disposition of the Common Stock in violation of the Securities Act or the
General Rules and Regulations promulgated thereunder by the Securities and
Exchange Commission (the "SEC") or in violation of any applicable state
securities law.

         Purchaser has been advised that the Common Stock has not been
registered under the Securities Act or state securities laws on the ground that
this transaction is exempt from registration, and that reliance by the Company
on such exemptions is predicated in part on Purchaser's representations set
forth in this letter.

         Purchaser has been informed that under the Securities Act, the Common
Stock must be held indefinitely unless it is subsequently registered under the
Securities Act or unless an exemption from such registration (such as Rule 144)
is available with respect to any proposed transfer or disposition by Purchaser
of the Common Stock. Purchaser further agrees that the Company may refuse to
permit Purchaser to sell, transfer or dispose of the Common Stock (except as
permitted under Rule 144) unless there is in effect a registration statement
under the Securities Act and any applicable state securities laws covering such
transfer, or unless Purchaser furnishes an opinion of counsel reasonably
satisfactory to counsel for the Company, to the effect that such registration is
not required.

         Purchaser also understands and agrees that there will be placed on the
certificate(s) for the Common Stock, or any substitutions therefor, a legend
stating in substance:
<PAGE>
         "The shares represented by this certificate have not been registered
         under the Securities Act of 1933, as amended (the "Securities Act"), or
         any state securities laws. These shares have been acquired for
         investment and may not be sold or otherwise transferred in the absence
         of an effective registration statement for these shares under the
         Securities Act and applicable state securities laws, or an opinion of
         counsel satisfactory to the Company that registration is not required
         and that an applicable exemption is available."

         Purchaser has carefully read this letter and has discussed its
requirements and other applicable limitations upon Purchaser's resale of the
Common Stock with Purchaser's counsel.

                                        Very truly yours,

                                        By:

                                        Title:<PAGE>

                              OFFICER'S CERTIFICATE

         I do hereby certify and represent that:

         1. I am the duly elected Secretary of deCODE genetics, Inc., a Delaware
corporation.

         2. Pursuant to Rule 306(a) of Regulation S-T, the following Exhibit 4.2
to deCODE genetics, Inc.'s Quarterly Report on Form 10-Q is a fair and accurate
English translation of a document prepared in the Icelandic language.

         IN WITNESS WHEREOF, I have signed this Officer's Certificate in my
capacity as Secretary of deCODE genetics, Inc. on this 15th day of May, 2002.

                                         By:    /s/ Tanya Zharov
                                                -------------------------------
                                         Name:  Tanya Zharov
                                         Title: Secretary and Corporate Counsel
<PAGE>
                                 ISK 10,000,000.
                                  Indexed Bond
                              Vetrargarourinn ehf.
                State Reg. No. 581201-2490 acknowledges owing to

<TABLE>
<S>                                                   <C>
Islandsbanki-FBA hf.
--------------------------------------------------------------------------------
Name

Kirkjusandur 2, 155 Reykjavik                         550500-3530
--------------------------------------------------------------------------------
Address                                               Reg. No.
</TABLE>

                             ISK ten million 00/100

The debt is linked to the consumer price index based on the index base of
January 2002, which was 219.5 points. The principal of the debt will be adjusted
in proportion to changes in the index from the index base to the first date of
payment and then in proportion to changes in the index between subsequent due
dates. The principal of the debt shall be adjusted on each due date, prior to
the calculation of the interest and the instalment. Instalments are calculated
as follows: inflation adjustments are added to the principal on each due date
and the total is then divided by the number of remaining due dates, including
the current due date.

On the principal, as current at any time, a fixed annual interest of 8.5% shall
be paid, calculated from 1 January 2002. Interest shall be paid in arrears, on
the same due dates as the instalments.

The Bond has a final maturity date of 1 December 2008. The principal shall be
paid in 7 equal instalments annually, the first on 1 December 2002.

As surety for the prompt and full payment of this debt and a debt pursuant to a
Loan Agreement with Islandsbanki-FBA hf. dated 21 December 2001 in the amount of
USD 4,000,000.- the issuer, Vetrargarourinn ehf. (formerly Sturlugata 8 ehf.),
has issued two general bonds secured by a lien in the property Sturlugata 8,
Reykjavik The first, secured by a first-rank mortgage, amounts to ISK
1,400,000,000.- and USD 4,000,000.- and is labelled Document No. B-24308/2001 in
the Register of Liens of the District Commissioner of Reykjavik. The second,
secured by a second-rank mortgage on the property, amounts to ISK 140,000,000.-
and USD 400,000.- and is labelled Document No. B-24309/2001 in the Register of
Liens of the District Commissioner of Reykjavik. The General Bonds are issued
both to Islandsbanki-FBA hf. on their own behalf and on behalf of the owners of
the Bond. FURTHERMORE, AN AGREEMENT HAS BEEN CONCLUDED WITH THE SECURED PARTIES,
DATED 21 DECEMBER 2001, PROVIDING FOR THE OBLIGATIONS OF THE PARTIES TO THE
AGREEMENT AND THE RESPECTIVE LEGAL POSITIONS OF THE SECURED PARTIES.

As surety for the prompt and full payment of this debt, the following parties
assume a guarantee in solidum. The guarantee shall remain in effect until the
debt is fully paid, regardless of whether a payment deferral on the debt is
granted.

<TABLE>
<S>                                                        <C>
Islensk erfoagreining ehf., State Reg. No. 691295-3549     Lynghals 1, Reykjavik

For deCODE genetics Inc., Delaware, United States of       Lynghals 1, Reykjavik
America
</TABLE>

In the event of any default on the payment of instalments or interest on this
Bond, the total amount of the debt may be called in immediately and without
notice. Default interest shall then be paid pursuant to the decision of the
Central Bank of Iceland at any time regarding
<PAGE>
default interest rates and default margins, cf. Article 6, Paragraph 1 of the
Interest Act No. 38/2001, on the due or called-in amount pursuant to the above.
The same applies if the principal Borrower or Guarantor seeks composition or
their estates are subjected to bankruptcy proceedings. When the debt is due
pursuant to the above, enforcement measures may be taken against the Borrower
and the Guarantors in order to secure payment of the debt without prior court
judgement or court settlement pursuant to item 7 of Paragraph 1 of Article 1 of
Act No. 90/1989. In addition to the principal of the debt, the enforcement right
extends to interest, price-level adjustments, penalty interest and claim costs,
costs of legal proceedings and collecting costs, repayment costs of the
proceedings themselves and projected costs of further enforcement proceedings.

The Bond may be assigned to an identified party.

The Borrower shall pay the stamp duties in respect of this Bond.

Any disputes arising in respect of this Bond may be brought before the District
Court of Reykjavik pursuant to the provisions of Chapter 17 of Act No. 91/1991.

The place of payment is Vetrargarourinn ehf., Sturlugata 8, 101 Reykjavik and
the Creditor may collect payment on submission of the Bond. The collection of
the debt may also be assigned to Islandsbanki-FBA or another party, provided
that the said collecting party sends notice of payment to Vetrargarourinn ehf.
containing the reference number specified in the top right-hand corner of this
bond.

In witness whereof, the signatures of the Issuer and the Guarantors are attached
in the presence of witnesses.

                            Reykjavik, 3 January 2002

                            For Vetrargarourinn ehf.

                            Tomas Sigurosson [sign.]

In agreement with the above as guarantors:

For Islensk erfoagreining ehf.

Tomas Sigurosson [sign.]

For deCODE genetics, Inc.

Tomas Sigurosson [sign.]

Witnesses to the correct date, signature and financial competence of the Issuer
and Guarantors:

Aoalsteinn E. Jonasson, Id. No 181266-4309

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00039-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00039-of-00352.parquet"}]]